BioSpace News Archive

Abpro Corporation today announced the initiation of global Phase 2/3 registrational studies evaluating the safety, tolerability, efficacy, and pharmacokinetics of ABP 300, a human neutralizing antibody for the treatment of COVID-19 derived from patients who have recovered from the SARS-CoV2 infection.

Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 21, 2020. The NBI is designed t

Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation, is pleased to announce that it has reported record 2020 revenues for three and nine months ended October 31, 2020.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the appointment of Andy Kidd, the company’s current chief operating officer, to the role of president and chief operating officer, effective December 14, 2020.

Elite Testing and Wellness at the Chastain Surgery Center is excited to announce the launch of innovative genetic testing and IV drip therapy services in the Atlanta market.

Vertice Pharma, a specialty pharmaceuticals company focused on improving patients’ health, today announced that Sandra Miceli will join the Company as Chief Financial Officer (“CFO”), reporting to Scott Meyers , Chief Executive Officer (“CEO”). Ms. Miceli brings over 25 years of experience in successful pharmaceutical

Catherine “Cathy” Kotz, PhD, FTOS, a leading researcher into the neuroscience of obesity and energy balance is the new president of The Obesity Society (TOS), the organization announced today.

Enveda Biosciences today announced its seed round of funding in the amount of $4.9 million led by True Ventures, with participation from Wireframe Ventures, Village Global and angel investor Chris Gibson (co-founder and CEO of Recursion). The seed round will enable Enveda to grow its medicinal plant dataset, enhance it

As clinical testing in Pennsylvania nears completion for pro and point of care GenViro! kits, Korean partner initiates PCR validation testing to augment testing of their saliva donors and the XPRIZE samples DECN plans 150 patient donor study to complete its at-home testing kit EUA LOS ANGELES, CA / ACCESSWIRE / December 16, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide distributor of diabetic test strips engineered

Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being offered in all 50 states